NCT05812365View on ClinicalTrials.gov

Best End-Expiratory and Driving-pressure for Individualized Flow Controlled Ventilation in Patients With COPD

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 24, 2024

Study Completion Date

July 24, 2024

Conditions

COPDVentilator LungAnesthesia

Trial Locations (1)

20246

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors

collaborator

Ventinova Medical, Eindhoven, Netherlands

UNKNOWN

collaborator

Timple SA, Rua Simao Álvares 356 Conj. 41,42 e 51 - Pinheiros, Sao Paulo (Brasilien)

UNKNOWN

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT05812365 - Best End-Expiratory and Driving-pressure for Individualized Flow Controlled Ventilation in Patients With COPD | Biotech Hunter | Biotech Hunter